Ticker
MXCTCompany Name
MAXCYTE INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 219.75M | $ 15.22M | 6.93% |
3/31/2025 | $ 229.96M | $ 23.39M | 10.17% |
12/31/2024 | $ 239.47M | $ 27.88M | 11.64% |
9/30/2024 | $ 248.61M | $ 36.96M | 14.87% |
6/30/2024 | $ 251.5M | $ 37.51M | 14.92% |
3/31/2024 | $ 257.93M | $ 22.25M | 8.63% |
12/31/2023 | $ 268.27M | $ 46.51M | 17.34% |
9/30/2023 | $ 266.73M | $ 49.17M | 18.43% |
6/30/2023 | $ 271.2M | $ 54.56M | 20.12% |
3/31/2023 | $ 281.54M | $ 37.83M | 13.44% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for MAXCYTE INC is calculated as follows: CashnEq [ $ 18.76M ] / Assets [ $ 51.78M ]
(=) Cash to Assets [ 36.22% ]
Minimum
Dec 31, 2022
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.8% |
average | 9.79% |
median | 6.44% |
std | 9.55% |